Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delphi Genetics
Charleroi (Gosselies), Wallonie, Belgium
- Ownership
- Private
- Development stage
- Other
01
Overview
Delphi Genetics established a reputation as a leading CDMO for plasmid DNA and recombinant protein production using its proprietary Staby® technology, supporting large pharma clients and facilitating gene and cell therapy manufacturing at GMP and clinical stages. Following acquisition, the facilities and expertise have been integrated into Catalent's global cell and gene therapy infrastructure
- Modalities
- Plasmid DNARecombinant proteinAntibodyDNA vaccine
- Industry
- Contract Manufacturing Organization
02
Partnerships
Licensed Staby® technology to major pharma clientsnow under Catalent partnerships
Beyond the preview
Go deeper on Delphi Genetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Delphi Genetics.